在严重的喘和带鼻息肉的慢性鼻炎中成功切换为tzepelumab
Yoshiro Kai1,2, Keiji Yoneyama3
1Department of Respiratory Medicine, Minami-Nara General Medical Center, Oyodo-cho, Japan.
Asia Pacific allergy
|September 11, 2025
概括
当其他疗法失败时,Tezepelumab成功治疗了一名患有严重喘和慢性鼻炎与鼻 (CRSwNP) 的患者. 这表明tzepelumab可以全面控制上下呼吸道的状况.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 带鼻息肉的慢性鼻炎 (CRSwNP) 是一种2型炎症性疾病,通常与喘同时发生.
- 目前的手术和口服皮质类固醇等治疗方法存在局限性,包括复发和不良反应.
- 有效管理CRSwNP和喘对于患者的整体健康至关重要.
研究的目的:
- 报告使用tezepelumab成功治疗与CRSwNP并发症的严重喘.
- 评估tezepelumab在对其他生物疗法的耐药性患者中的疗效.
主要方法:
- 患者最初接受了标准治疗,然后接受了包括dupilumab和mepolizumab在内的生物疗法.
- 由于治疗失败和不良反应,治疗被切换为tezepelumab,一种抗胸膜 stromal lymphopoietin单克隆抗体.
- 对喘和CRSwNP的临床结果进行了监测.
主要成果:
- 杜皮卢马布和梅波利祖马布显示部分或暂时的益处,但与不良事件相关,如过敏氨基酸和症状复发.
- 采佩卢马布治疗导致了喘症状和CRSwNP控制的改善.
- 患者在tzepelumab治疗下经历了改善的喘控制和减少鼻腔症状.
结论:
- 泰泽佩卢马布在治疗伴并发性CRSwNP的严重喘方面显示出潜在的有用性.
- 这种生物制剂可以全面控制上下呼吸道疾病.
- 需要进一步的研究来证实tzepelumab在治疗这些复杂疾病中的作用.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
1.8K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
COPD: Management Using Bronchodilators and Corticosteroids
741
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
741
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K


